Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Anavex Life Sciences (AVXL)

$1.28 −$0.05 (−3.76%)

Day’s range
$1.25–$1.31
Volume
912,371

AVXL price history

AVXL closed at $1.28 on Oct. 26, 2026. Over the past year, its daily close ranged from $1.25 on Oct. 19, 2026 to $8.49 on Oct. 27, 2025.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $0 to $10, not from zero.
Data table: AVXL daily closes, the past year
AVXL daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$1.28
Oct. 23, 2026$1.33
Oct. 22, 2026$1.36
Oct. 21, 2026$1.36
Oct. 20, 2026$1.36
Oct. 19, 2026$1.25
Oct. 16, 2026$1.31
Oct. 15, 2026$1.48
Oct. 14, 2026$1.49
Oct. 13, 2026$1.48
Oct. 12, 2026$1.51
Oct. 9, 2026$1.49
Oct. 8, 2026$1.54
Oct. 7, 2026$1.53
Oct. 6, 2026$1.60
Oct. 5, 2026$1.65
Oct. 2, 2026$1.82
Oct. 1, 2026$1.89
Sept. 30, 2026$2.02
Sept. 29, 2026$2.36
Sept. 28, 2026$2.35
Sept. 25, 2026$2.38
Sept. 24, 2026$2.34
Sept. 23, 2026$2.35
Sept. 22, 2026$2.47
Sept. 21, 2026$2.40
Sept. 18, 2026$2.42
Sept. 17, 2026$2.41
Sept. 16, 2026$2.36
Sept. 15, 2026$2.44
Sept. 14, 2026$2.60
Sept. 11, 2026$2.62
Sept. 10, 2026$2.66
Sept. 9, 2026$2.75
Sept. 8, 2026$2.85
Sept. 4, 2026$2.86
Sept. 3, 2026$2.85
Sept. 2, 2026$2.89
Sept. 1, 2026$2.87
Aug. 31, 2026$2.80
Aug. 28, 2026$2.99
Aug. 27, 2026$3.13
Aug. 26, 2026$3.24
Aug. 25, 2026$3.56
Aug. 24, 2026$3.11
Aug. 21, 2026$3.24
Aug. 20, 2026$3.13
Aug. 19, 2026$3.39
Aug. 18, 2026$3.20
Aug. 17, 2026$3.21
Aug. 14, 2026$3.22
Aug. 13, 2026$3.27
Aug. 12, 2026$3.41
Aug. 11, 2026$3.51
Aug. 10, 2026$3.39
Aug. 7, 2026$3.34
Aug. 6, 2026$3.28
Aug. 5, 2026$3.20
Aug. 4, 2026$3.15
Aug. 3, 2026$2.95
July 31, 2026$2.75
July 30, 2026$2.70
July 29, 2026$2.49
July 28, 2026$2.57
July 27, 2026$2.50
July 24, 2026$2.40
July 23, 2026$2.48
July 22, 2026$2.55
July 21, 2026$2.56
July 20, 2026$2.42
July 17, 2026$2.39
July 16, 2026$2.34
July 15, 2026$2.50
July 14, 2026$2.43
July 13, 2026$2.35
July 10, 2026$2.50
July 9, 2026$2.70
July 8, 2026$2.70
July 7, 2026$2.71
July 6, 2026$2.66
July 2, 2026$2.76
July 1, 2026$2.58
June 30, 2026$2.59
June 29, 2026$2.60
June 26, 2026$2.62
June 25, 2026$2.47
June 24, 2026$2.56
June 23, 2026$2.58
June 22, 2026$2.54
June 18, 2026$2.73
June 17, 2026$2.67
June 16, 2026$2.52
June 15, 2026$2.50
June 12, 2026$2.50
June 11, 2026$2.50
June 10, 2026$2.46
June 9, 2026$2.54
June 8, 2026$2.62
June 5, 2026$2.57
June 4, 2026$2.82
June 3, 2026$2.65
June 2, 2026$2.79
June 1, 2026$2.98
May 29, 2026$3.03
May 28, 2026$2.94
May 27, 2026$2.76
May 26, 2026$2.71
May 22, 2026$2.70
May 21, 2026$2.71
May 20, 2026$2.75
May 19, 2026$2.67
May 18, 2026$2.88
May 15, 2026$2.91
May 14, 2026$3.08
May 13, 2026$3.08
May 12, 2026$3.06
May 11, 2026$3.24
May 8, 2026$3.22
May 7, 2026$3.12
May 6, 2026$3.34
May 5, 2026$3.36
May 4, 2026$3.41
May 1, 2026$3.32
April 30, 2026$3.34
April 29, 2026$3.26
April 28, 2026$3.37
April 27, 2026$3.29
April 24, 2026$3.34
April 23, 2026$3.31
April 22, 2026$3.61
April 21, 2026$3.50
April 20, 2026$3.65
April 17, 2026$3.64
April 16, 2026$3.40
April 15, 2026$3.24
April 14, 2026$3.12
April 13, 2026$3.11
April 10, 2026$2.95
April 9, 2026$3.05
April 8, 2026$3.04
April 7, 2026$3.08
April 6, 2026$2.96
April 2, 2026$2.99
April 1, 2026$3.10
March 31, 2026$3.07
March 30, 2026$2.82
March 27, 2026$2.82
March 26, 2026$2.88
March 25, 2026$2.74
March 24, 2026$4.19
March 23, 2026$4.44
March 20, 2026$4.06
March 19, 2026$4.20
March 18, 2026$4.26
March 17, 2026$4.55
March 16, 2026$4.71
March 13, 2026$4.65
March 12, 2026$4.65
March 11, 2026$4.65
March 10, 2026$4.64
March 9, 2026$4.79
March 6, 2026$4.65
March 5, 2026$4.76
March 4, 2026$5.00
March 3, 2026$4.69
March 2, 2026$4.53
Feb. 27, 2026$4.43
Feb. 26, 2026$4.46
Feb. 25, 2026$4.40
Feb. 24, 2026$4.36
Feb. 23, 2026$4.16
Feb. 20, 2026$4.12
Feb. 19, 2026$4.12
Feb. 18, 2026$4.04
Feb. 17, 2026$4.04
Feb. 13, 2026$3.93
Feb. 12, 2026$3.92
Feb. 11, 2026$3.88
Feb. 10, 2026$3.96
Feb. 9, 2026$4.35
Feb. 6, 2026$4.10
Feb. 5, 2026$3.81
Feb. 4, 2026$4.13
Feb. 3, 2026$4.39
Feb. 2, 2026$4.52
Jan. 30, 2026$4.70
Jan. 29, 2026$4.91
Jan. 28, 2026$4.87
Jan. 27, 2026$5.05
Jan. 26, 2026$5.02
Jan. 23, 2026$5.26
Jan. 22, 2026$5.30
Jan. 21, 2026$5.30
Jan. 20, 2026$5.03
Jan. 16, 2026$5.01
Jan. 15, 2026$4.85
Jan. 14, 2026$4.82
Jan. 13, 2026$4.64
Jan. 12, 2026$4.29
Jan. 9, 2026$4.28
Jan. 8, 2026$4.27
Jan. 7, 2026$4.10
Jan. 6, 2026$4.01
Jan. 5, 2026$3.95
Jan. 2, 2026$3.68
Dec. 31, 2025$3.56
Dec. 30, 2025$3.80
Dec. 29, 2025$3.65
Dec. 26, 2025$3.64
Dec. 24, 2025$3.72
Dec. 23, 2025$3.73
Dec. 22, 2025$3.75
Dec. 19, 2025$3.67
Dec. 18, 2025$3.89
Dec. 17, 2025$3.92
Dec. 16, 2025$4.02
Dec. 15, 2025$4.14
Dec. 12, 2025$4.02
Dec. 11, 2025$4.11
Dec. 10, 2025$4.08
Dec. 9, 2025$4.41
Dec. 8, 2025$4.34
Dec. 5, 2025$4.40
Dec. 4, 2025$4.45
Dec. 3, 2025$4.57
Dec. 2, 2025$3.67
Dec. 1, 2025$3.82
Nov. 28, 2025$3.83
Nov. 26, 2025$3.86
Nov. 25, 2025$3.46
Nov. 24, 2025$3.08
Nov. 21, 2025$3.26
Nov. 20, 2025$3.17
Nov. 19, 2025$3.60
Nov. 18, 2025$3.50
Nov. 17, 2025$3.58
Nov. 14, 2025$3.65
Nov. 13, 2025$5.69
Nov. 12, 2025$6.90
Nov. 11, 2025$6.85
Nov. 10, 2025$6.49
Nov. 7, 2025$7.29
Nov. 6, 2025$7.40
Nov. 5, 2025$7.31
Nov. 4, 2025$7.47
Nov. 3, 2025$7.74
Oct. 31, 2025$7.97
Oct. 30, 2025$8.03
Oct. 29, 2025$8.02
Oct. 28, 2025$8.10
Oct. 27, 2025$8.49

Key figures

52-week range
$1.25–$8.62Low Oct. 19, 2026; high Oct. 24, 2025
Average daily volume
1.0MPast 3 months
Market value
$118.7M
Dividend yield
—
From 52-week high
−85.14%

Price change

1 month
−46.22%
3 months
−46.67%
Year to date
−64.04%
1 year
−85.14%

$1,000 a year ago

$1,000 put into AVXL at the close on Oct. 24, 2025 would be worth $149.

Price only, dividends not included.

What Wall Street says about AVXL

No Wall Street firm has published a rating or price-target change on AVXL in the past 90 days.

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Anavex Life Sciences

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Headquarters
New York, N.Y.
Employees
34
Listed
Aug. 2, 2006
Sector
Health care
Industry
Biological products, (no diagnostic substances)

anavex.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about AVXL is on the site yet.

  • AMGNAmgen Inc
  • GILDGilead Sciences Inc
  • MRNAModerna, Inc. Common Stock
  • RVMDRevolution Medicines, Inc. Common Stock
  • BIIBBiogen Inc. Common Stock
  • EXELExelixis Inc